Cytotoxicity of copper complexes of 2-furaldehyde oxime derivatives in murine and human tissue cultured cell lines

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2411-2418

  Hall, Iris H ^a   Taylor, Karen ^a   Miller III, M C ^a   Dothan, X ^b   Khan, Mustayeen A ^b   Bouet, Fgilles M ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Complexes of furan oximes; Copper; Cytotoxicity; IMP dehydrogenase; Nucleic acid inhibitors; Purine inhibitors

Indexed keywords

ANTINEOPLASTIC AGENT; COPPER COMPLEX; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; FURFURAL; OXIME; PHOSPHOTRANSFERASE; PURINE; RNA POLYMERASE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SUSPENSION; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURINE SYNTHESIS; RNA SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SURVIVAL; COPPER; DNA, NEOPLASM; FURALDEHYDE; HUMANS; LEUKEMIA L1210; NEOPLASM PROTEINS; OXIMES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030758558     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 2] in Ehrlich Ascites Carcinoma, J Pharm Sci 73: 222-225, 1984.
2. Hall IH, Morse KW, Spielivogel BF and Sood,A: DNA interaction with metal complexes and salts of substituted boranes and hydroborates in murine and human tumor cell lines, Anti-cancer Drugs 2: 389-399, 1991.
3. West DX, Liberta AE, Rajendran KG and Hall IH: The cytotoxicity of heterocylic thiosemicarbazones of copper (II) complexes. Anti-Cancer Drugs 4: 231-240, (1993).
4. West DX, Rajendran KG, Liberia AE and Hall IH: The Cytotoxicity of a Heterocylic Thiosemicarbazones or their metal complexes on human and murine tissue culture cells. Anti-Cancer Drugs 4: 241-249, (1993).
5. Hall IH, Bouet GM, Lee C: The cytotoxicity of metallic complexes of furan oximes in murine and human cultured cells. Appl Met Org Chem In press, 1997.
6. Bouet G and Dugue M, Metal complexes with 2-furfuraldoxime, Transition Met Chem 15: 257-263, (1990).
7. Bouetm G, Dugue Jand Keller-Besst F: Metallic complexes with furan oximes Part IV. Synthesis and characterization of 5-substituted 2-furfuraldoxime complexes with 3d element dihalides. Transition Met Chem 15: 5-8 (1990).
8. Geran RJ, Greenberg NH, Macdonald MM, Schumacher AM and Abbott BJ: Protocol for screening chemical agents and natural products against animal tumor and other biological systems. Cancer Chemother Rep 3: 7-24, 1972.
9. Leibovitz AL, Stinson JC, McComb III WB, McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562-4569, 1976.
10. Liao LL, Kupchan SM and Horwitz SB: Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol Pharmacol 12: 167-176, 1976.
11. Cadman E, Heimer R, and Benz C: The influence of methotrexate pretreatment on 5-flurouracil metabolism in L1210 cells. J Biol Chem 256: 1695-1704, 1981.
12. Christopherson RI, Yu ML, and Jones M: An overall radioassay for the first three reactions of de novo pyrimidine synthesis. Anal Biochem 111: 240-249, 1981.
13. Eichler DC, Fisher PA, and Korn D: Effect of calcium on the recovery distribution of DNA polymerase α from cultured human cells. J Biol Chem 252: 4011-4014, 1977.
14. Sedwick WD, Wang TS and Korn D: Purification and properties of nuclear and cytoplasmic deoxyribonucleic acid polymerases from human KB cells, J Biol Chem 247: 5026-5033, 1972.
15. Sawada H, Tatsumi K, Sadada M, Shirakawa S, Nakamura T, Wakisaka G: Effects of neocarzinostatin on DNA synthesis in L1210 cells. Cancer Res 34: 3341-3346, 1974.
16. Hall IH, Carlson GL, Abernathy GS, and Piantadosi C: Cycloalkanones IV. Antifertility agents. J Med Chem 17: 1253-1257, 1974.
17. Anderson KM, Mendelson IS, and Guizik G: Solubilized DNA-dependent nuclear RNA polymerases from the mammary glands of late-pregnant rats. Biochem Biophys Acta 383: 56-66, 1975.
18. Moore EC, and Hulbert RB: Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors. J Biol Chem 241: 4802-4809, 1966.
19. Maley F and Ochoa S: Enzymatic phosphorylation of deoxycytidylic acid. J Biol Chem 233: 1538-1543, 1958.
20. Kalman SM, Duffield PH and Brzozwki TJ: Purification and properties of a bacterial carbamyl phosphate synthetase. J Biol Chem 241: 1871-1877, 1966.
21. Achibald RM: Determination of citrulline and allontoin and demonstration of citrulline in the blood plasma. J Biol Chem 156: 121-142, 1944.
22. Koritz SB and Cohen PP: Colorimetric determination of carbamyl amino acid and related compounds. J Biol Chem 209: 145-150, 1954.
23. Kampf A, Bariknecht R, Schaffer P, Osaki S, and Merles MP: Synthetic inhibitors of E. Coli calf thymus and Ehrlich ascites tumor thymidylate synthetase. J Med Chem 19: 903-908, 1976.
24. Ho YK, Hakala T and Zakrzewski S: 5-(1-Adamantyl)pyrimidines as inhibitors of folate metabolism. Cancer Res 32: 1023-1028, 1972.
25. Spassova MK, Russev GC and Goovinsky EV: Some pyrazoles as inhibitors of purine biosynthesis de novo. Biochem Pharmacol 25: 923-924, 1976.
26. Becker JH, and Lohr GW: Inosine 5′-phosphate dehydrogenase activity in normal and leukemic blood cells. Klin Wochenschr 57: 1100-1115, 1979.
27. Lowry OH, Rosebrough J, Farr AL and Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951.
28. Bagnara AS and Finch LR: Quantitative extraction and estimation of intracellular nucleoside triphosphates in E. Coli. Anal Biochem 45: 24-34, 1972.
29. Hunting D and Henderson J: Determination of deoxyribonucleoside triphosphates using DNA polymerase a: A critical evaluation. Can J Biochem 59: 723-727, 1981.
30. Suzuki H, Nishimura T, Muto SK, Tanaka N: Mechanism of action of macromomycin: DNA strand scission, inhibition of DNA synthesis, mitosis. J Antibacteriol 32: 875-883, 1978.
31. Pera JF Sr, Rawlings CJ, Shackleton J, Robert JJ: Quantitation aspects of the formation and loss of DNA. Biochem Biophy Acta 655: 152-166, 1981.
32. 3 cells by cytoxic and antitumor sesquiterpine lactones. Biocehm Pharmacol 30: 3005-3007, 1981.
33. Zhao Y, Hall IH, Oswald CB, Yokoi T, Lee KH: Anti-malarial agents III. Mechanism of action of artesunate against Plasmodium berghi infection. Chem Pharm Bull 35: 2052-2061, 1987.
34. Liu, LF, Rowe TC, Yang L, Tewey KM and Chen GL: Cleavage of DNA by mammalian DNA topoisomerase 11. J Biol Chem 258: 15365-15370, 1983.
35. Liu LF, Davis JD, and Calendra R: Novel topological knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerase. Nucleic Acid Res 9: 3979-3989, 1981.
36. Rowe TC, Chen GL, Hsiang, YH and Liu LF: DNA damage by acridines mediated by DNA topoisomerase II. Cancer Res 46: 2021-2026, 1986.
37. Rose KM: DNA topoisomerases as targets for chemotherapy, FASEB J 2, 2474-2478, 1988.
38. DeVore RF, Corbett AH and OsheroffN: Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enyzme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4′-(9-acridinylamino)methanesulfon-m-ansidide. Cancer Res 52: 2156-2161, 1992.
39. Miller MC III: Synthesis and Pharmacology of Dipeptides and Metal Complexes of Aminecarboxyborane Adducts, Ph.D. Thesis, May 1996, University of North Carolina.
40. Rappa G, Lorico A, and Sartorelli AC: Reversal of etoposide resistance in non-p-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin, Cancer Res 53: 5487-5493, 1993.
41. Tanabe K, Ikegami Y, Ishida R and Andoh T: Inhibition of topoisomerase II by anti-tumor agent bis(2,6-dioxopiperazine) derivatives. Cancer Res 57: 4903-4908, 1991.
42. Boritzki TJ, Wolfard TS, Besserer JA, Jackson RA and Fry DW: Inhibition of type II topoisomerase by fostriecin, Biochem Pharm 37: 4063-4068, 1988.
43. Hotz MA, DelBino G, Lassota P, Traganos F and Darzynkiewicz, Z: Cyostatic and cytotoxic effects of fostriencin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemia cells, Cancer Res 52: 1530-1535, 1992.